Log in
Research report
➢ 投资逻辑:估值回调充分,Q4有望实现业绩高增长市场悲观预期已充分反应,当前投资性价比较高。截止2023/11/3,重点医疗服务企业中爱尔眼科动态PE为51.2倍,处于近十年PE的0.21%分位点;华厦眼科动态PE为49.96倍,处于上市以来的0.41%分位点;普瑞眼科动态PE为62.41倍,处于上市以来的0.93%分位点;通策医疗动态PE为52.9倍,处于近十年PE的16.27%分位点;海吉亚
Read full report →No related industries
No related institutions
No related reports